Gadoterate Meglumine Injection — FDA Drug Shortage

To Be Discontinued — Jiangsu Hengrui Pharmaceuticals Co., Ltd.

The FDA lists a drug shortage record for Gadoterate Meglumine Injection (injection) from Jiangsu Hengrui Pharmaceuticals Co., Ltd. with status To Be Discontinued. The shortage was first posted on May 21, 2026.

Shortage details

Status
To Be Discontinued
Company
Jiangsu Hengrui Pharmaceuticals Co., Ltd.
Package NDC
65219-080-05
Dosage Form
Injection
Presentation
Gadoterate Meglumine, Injection, 376.9 mg/1 mL (NDC 65219-080-05)
Initial Posting
May 21, 2026

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.